Celldex Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$38.24

-0.74 (-1.90%)

As of Sep 20, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 91%

Hold 2 9%

Sell 0 0%

Price Target

Analyst Price Target +36.2% upside

Low Target $39.61

Average Target $52.08

High Target $81.09

Current Price $38.24

Current
$38.24

Target
$52.08

$39.61 $52.08 avg $81.09

Scenario Analysis

Bear Case

$39.61

3.6%

Low target

Base Case

$52.08

+36.2%

Avg target

Bull Case

$81.09

+112.1%

High target

Risk/Reward

31.3x

Highly favorable

Price in Context

52-Week High

$45.14

-15.3% from high

52-Week Low

$22.10

+73.0% from low

Target vs 52W High

$52.08

+15.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%